Early-phase consumer investor led by founders with extensive experience investing in and advising consumer businesses, backing purpose-driven innovators building emerging brands and enabling technologies. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Early-phase partner for founders building iconic, industry-transforming companies, demonstrated by two new funds totaling $347M. With a disciplined investment approach, the team drives value for both founders and investors.
Women-led VC systematically backs clinically rigorous, behaviorally grounded wellbeing nascent-stage companies tackling stigmatized areas—alcohol use disorder, menopause, mental health—using stigma as an investing edge and insisting on consumer-grade UX. With a disciplined investment approach, the team drives value for both founders and investors.
Deliberate 60/40 tech/healthcare split dedicated to de novo company formation, with a transparent debate-driven partner scoring system (1–4) and proven multi-generation continuity. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
Invests at the pre-venture stage, applies a proprietary Villain Test to avoid future-harmful giants, features rapid small grants to de-risk climate ideas, and backs culture-shaping consumer brands. With a disciplined investment approach, the team drives value for both founders and investors.
Seed and formative-stage lead/co-lead investor backing veteran teams in education, safety & care, and environment/climate, delivering Goldman-level analytical rigor and explicit, quantified impact theses. With a disciplined investment approach, the team drives value for both founders and investors.
Backs edge-technology founders, fund managers and ecosystem builders, delivering Opportunity Hub–integrated training (BTEI), capital pathways, and co-creation of place-based equity districts and wealth initiatives. The firm continues to build its presence across the venture capital landscape.
